Epidemiological Studies and Risk Factor Analysis of Gastroesophageal Reflux Diseases in Xiamen City: a Cross-sectional Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Gastroesophageal Reflux Disease (GERD) is a condition characterized by the reflux of gastric and duodenal contents into the esophagus, primarily manifested by symptoms such as acid regurgitation and heartburn. GERD significantly affects patients' daily lives and health-related quality of life. Prolonged gastroesophageal reflux can lead to repeated irritation of the esophageal mucosa by gastric acid and acidic gastric contents, resulting in the replacement of normal squamous epithelium in the lower esophagus with metaplastic columnar epithelium. This pathological change, known as Barrett's Esophagus (BE), is considered a precancerous lesion for esophageal adenocarcinoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 75
Healthy Volunteers: f
View:

• All patients had experienced typical reflux symptoms, i.e., mild heartburn and/or regurgitation symptoms, for at least 2 days per week or moderate/severe reflux symptoms for more than 1 day per week during the previous 3 months and had upper endoscopy examinations in the previous month.

• Cooperate with the questionnaire survey.

• Volunteer and sign the informed consent form.

• Permanent residents in Xiamen.

Locations
Other Locations
China
Zhongshan Hospital (Xiamen), Fudan University
RECRUITING
Xiamen
Contact Information
Primary
Yucheng Zhu, Doctor
zhu.yucheng@zsxmhospital.com
86-592-3501990
Backup
Wei Jiang, Doctor
jiang.wei@zs-hospital.sh.cn
86-592-3501990
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 1600
Treatments
Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is a gastrointestinal motility disorder that results from the reflux of stomach contents into the esophagus or oral cavity resulting in symptoms or complications.
Sponsors
Leads: Zhongshan Hospital (Xiamen), Fudan University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials